Skip to main content
Clinical Trials/CTRI/2024/05/068084
CTRI/2024/05/068084
Not yet recruiting
Phase 1

To assess the utility of individualized homoeopathic medicine in management of cystitis. A single arm open label interventional study. - nil

Dr. Bilal Khan0 sites0 target enrollmentTBD

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Dr. Bilal Khan
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
Dr. Bilal Khan

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients of all age group.
  • 2\. Patients of all sexes.
  • 3\. Diagnostic criteria are mainly on clinical presentation and urine culture will be done when required.
  • 4\. Patient willing to participate in study and provide written consent.

Exclusion Criteria

  • 1\. Patients not willing to participate in the study.
  • 2\. Any medical condition or disease which might interfere with the assessments (e.g.MR, Hearing impairment or speech problems).
  • 3\. Patients suffering from Malignancy, Tuberculosis and Systemic disorders such as Diabetes Mellitus, Thyroid dysfunction etc.
  • 4\. Patients who require emergency medical treatment.
  • 5\. Cases of interstitial cystitis, hemorrhagic cystitis, malakoplakia, cystitis cystica.
  • 6\. Pregnant and lactating women.
  • 7\. Patient participating in any other clinical study.
  • 8\. Cases that do not fulfill the inclusion criteria.

Outcomes

Primary Outcomes

Not specified

Similar Trials